Clotting Factor BSc Nursing 1st Year, Pathways, Factors & Functions

Clotting factors are essential proteins that play a vital role in hemostasis, the process of stopping bleeding. Synthesized primarily in the liver, these factors circulate in the bloodstream in an inactive state, only becoming active when a blood vessel is injured. This activation triggers a cascade of reactions that ultimately lead to the formation of a stable blood clot, preventing further blood loss.

What Are Clotting Factors?

Clotting factors are proteins primarily synthesized by the liver. Their main function is to stop bleeding by forming a blood clot. For instance, if a blood vessel is injured, these factors quickly act at the site to halt blood flow.

Individuals with liver diseases, like liver cirrhosis, often face a higher risk of bleeding disorders because their liver's ability to produce these crucial factors is compromised.

Clotting factors circulate in the body in an inactive form. They become activated only when needed, specifically following an injury to blood vessels, remaining dormant otherwise. This activation initiates a chain reaction, where one activated factor triggers the next in sequence (e.g., Factor 12 activates 11, which activates 9, then 10). It is important for exams to remember that clotting factors are synthesized in the liver and circulate in an inactive form until needed.

Thrombus vs. Embolus

Understanding the difference between a thrombus and an embolus is crucial in medical contexts:

• Thrombus: This is a blood clot that forms within a blood vessel and remains stationary at its site of formation.

• Embolus: This refers to a blood clot (or other foreign material like fat or air) that detaches from its original site and travels through the bloodstream. An embolus can obstruct a blood vessel at a distant location, leading to serious conditions such as pulmonary embolism.

Why Are Clotting Factors Needed?

Clotting factors are vital for maintaining hemostasis by stopping bleeding after a blood vessel injury. When an injury occurs, clotting factors activate in a chain reaction, known as a coagulation cascade. This sequential activation means factors trigger one another: Factor 12 activates Factor 11, which then activates Factor 9, and so on. Any disruption in this sequence can lead to bleeding disorders.

This chain reaction culminates in the formation of fibrin, a protein that creates a fibrin mesh. This mesh stabilizes the blood clot at the injury site, effectively preventing further bleeding. For example, activated clotting factors and aggregated platelets accumulate at the injury site to form a stable mass that stops bleeding. Factor 12 is a main factor whose activation is critical for the subsequent activation of other factors (e.g., 11 and 9). Factor 10 forms the common pathway for both the intrinsic and extrinsic coagulation cascades.

The 12 Clotting Factors (I-XIII)

There are 13 named clotting factors, though Factor VI is absent, meaning there are 12 active factors. It is crucial to remember all 12 active clotting factors as they are frequently asked in university exams.

Here are the key clotting factors:

• Fibrinogen (Factor I) (Memory Tip: 'F' for Fibrinogen, 'P' for Prothrombin, 'T' for Tissue Factor, 'C' for Calcium, 'L' for Labile Factor - remembers the first five factors using "Freshers" for F, P, T, C, L)

• Prothrombin (Factor II)

• Tissue Factor / Thromboplastin (Factor III): This is the first factor to activate in the extrinsic pathway during tissue injury.

• Calcium (Factor IV)

• Labile Factor (Factor V)

• Absent (Factor VI)

• Stable Factor (Factor VII)

• Antihemophilic Factor A (Factor VIII): Its absence is associated with Hemophilia A.

• Christmas Factor / Antihemophilic Factor B (Factor IX): Its absence is associated with Hemophilia B.

• Stuart-Prower Factor (Factor X): This is a main factor where the common pathway for both intrinsic and extrinsic cascades is formed.

• Plasma Thromboplastin Antecedent (Factor XI)

• Hageman Factor (Factor XII)

• Fibrin-Stabilizing Factor (Factor XIII)

Coagulation Pathways

Blood clotting proceeds through two main pathways: the Intrinsic Pathway and the Extrinsic Pathway. Both pathways eventually converge into a Common Pathway.

Intrinsic Pathway

The intrinsic pathway is a contact activation pathway initiated by injury inside the blood vessels. When the endothelium (inner lining of blood vessels) is damaged, it exposes collagen. This exposure activates clotting factors already present within the blood itself. An example includes conditions like a heart attack, where internal blood vessel injury triggers this pathway.

Intrinsic Pathway Activation Sequence

1. Initiation by Factor XII: Damage to the endothelium exposes collagen, activating Hageman Factor (Factor XII) to Factor XIIa.

2. Contact Activation: This initial activation is called "contact activation" due to contact with exposed collagen.

3. Factor XI Activation: Factor XIIa then activates Factor XI to Factor XIa.

4. Factor IX Activation: Factor XIa, with calcium (Factor IV), activates Factor IX to Factor IXa.

5. Factor X Activation: Factor IXa then activates Factor X (Stuart-Prower Factor) to Factor Xa. Understanding this sequence is very important for exams.

Extrinsic Pathway

The extrinsic pathway is activated by tissue injury that occurs outside the blood vessels, such as trauma or fractures. This pathway relies on factors released from the damaged tissues themselves.

Extrinsic Pathway Details

Also known as the Tissue Factor pathway, it activates upon tissue injury outside the blood vessels:

1. Tissue Factor (Factor III, also Thromboplastin) is released from damaged tissues.

2. Factor III then combines with and activates Factor VII (Stable Factor).

3. This activated complex (Factor III and Factor VIIa) activates Factor X (Stuart-Prower Factor), which then enters the common pathway.

Common Pathway

Both the intrinsic and extrinsic pathways converge to activate Factor X. This activated Factor X (Factor Xa) marks the beginning of the common pathway.

Common Pathway Sequence

1. Prothrombin Activation: Activated Factor X (Factor Xa), along with Factor V (Labile Factor), Calcium (Factor IV), platelets, and phospholipids, forms a complex that converts Prothrombin (Factor II) into Thrombin (Factor IIa).

2. Fibrin Formation: Thrombin then converts Fibrinogen (Factor I) into Fibrin (an insoluble protein), initially forming a loose mesh.

3. Clot Stabilization: Thrombin also activates Factor XIII (Fibrin-Stabilizing Factor). Activated Factor XIII (Factor XIIIa) cross-links the loose fibrin strands, forming a stable fibrin clot that firmly seals the injury and stops bleeding.

In summary, the intrinsic pathway (Factor XII → XI → IX) and the extrinsic pathway (Tissue Factor III → Factor VII) both activate Factor X, initiating the common pathway. This leads to the conversion of Prothrombin to Thrombin, and Fibrinogen to Fibrin, which is then stabilized by Factor XIII to form a strong clot.

Key Functions and Clinical Importance of Blood Cells

This section highlights the major roles of blood cells, their involvement in immune and allergic responses, common disorders linked to their deficiency, and the normal lifespan of red blood cells.

Leukocyte Function in Allergic Reactions

The eosinophil is the leukocyte primarily responsible for allergic reactions.

Conditions Related to Blood Cell Deficiencies

When there is a deficiency of hemoglobin or a reduction in the number of Red Blood Cells, the condition is called Anemia.

• Thrombocytopenia relates to platelet conditions.

• Leukemia relates to White Blood Cells (WBCs) conditions.

Lifespan of Red Blood Cells

The typical life span of Red Blood Cells is 120 days.

Explore the Nursing Courses 2026 to access essential resources for Nursing exam preparation, including detailed insights and strategies. Dive into the Nursing 2026 for structured courses and focused study plans designed to help aspirants excel in their exams.